# Bolus vs. Continuous IV Lidocaine Against Post-Extubation Cough in Post-Thyroidectomy Patients

> **NCT06040034** · PHASE2 · COMPLETED · sponsor: **Universitas Padjadjaran** · enrollment: 40 (actual)

## Conditions studied

- Cough

## Interventions

- **DRUG:** Lidocaine IV

## Key facts

- **NCT ID:** NCT06040034
- **Lead sponsor:** Universitas Padjadjaran
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-02-02
- **Primary completion:** 2023-05-01
- **Final completion:** 2023-05-01
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2023-09-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06040034

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06040034, "Bolus vs. Continuous IV Lidocaine Against Post-Extubation Cough in Post-Thyroidectomy Patients". Retrieved via AI Analytics 2026-07-10 from https://api.ai-analytics.org/clinical/NCT06040034. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*